Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Citius Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Citius Pharmaceuticals Inc. April 6, 202670.7%
-
DarioHealth Corp. January 29, 202697.6%
-
DarioHealth Corp. July 23, 202593.5%
-
Citius Pharmaceuticals Inc. March 10, 202570.5%
-
DarioHealth Corp. December 18, 202498.7%
-
Citius Pharmaceuticals Inc. March 12, 202478.4%
-
DarioHealth Corp. December 11, 202385.1%
-
Citius Pharmaceuticals Inc. February 7, 202392.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | DarioHealth Corp. | Grant or award | +61,000 | — | — |
| Apr 2, 2026 | PAVmed Inc. | Grant or award | +180,000 | — | — |
| Feb 20, 2026 | Lucid Diagnostics Inc. | Grant or award | +470,000 | — | — |
| Sep 30, 2025 | PAVmed Inc. | Grant or award | +150,000 | — | — |
| Sep 19, 2025 | Citius Oncology Inc. | Grant or award | +300,000 | — | — |
| Sep 11, 2025 | DarioHealth Corp. | Grant or award | +20,000 | — | — |
| Feb 20, 2025 | Lucid Diagnostics Inc. | Grant or award | +300,000 | — | — |
| May 7, 2024 | Lucid Diagnostics Inc. | Grant or award | +400,000 | — | — |
| Mar 6, 2024 | DarioHealth Corp. | Grant or award | +80,000 | — | — |
Questions about Dennis M. Mcgrath
What boards is Dennis M. Mcgrath on?
Dennis M. Mcgrath sits on the boards of Citius Oncology Inc., Citius Pharmaceuticals Inc. and DarioHealth Corp.
How long has Dennis M. Mcgrath served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.